Abstract
The development of arthritis induced in mice by intraperitoneal injection of the non‐antigenic mineral oil, 2,6,10,14‐tetramethylpentadecane (pristane), was shown to depend on an intact immune response possibly to a heat‐shock protein (hsp) in the synovium. Initial experiments suggested that some crucial event in the development of arthritis takes place early after pristane injection. First, irradiated pristane‐treated mice failed to develop arthritis unless they were reconstituted with spleen cells from normal donors within 25 days of irradiation. Second, mice irradiated up to 50 days after pristane injection, but not later, did not develop arthritis. Evidence for the involvement of an immune response to heat‐shock protein (hsp) comes from the finding that mice injected with mycobacterial 65‐kDa hsp prior to pristane challenge had a reduced incidence of arthritis in contrast to animals pre‐immunized with the E. coli hsp equivalent GroEL or with bovine serum albumin. Other experiments revealed that T cells from mice with gross morphologically defined arthritis proliferated strongly to hsp65 and to normal joint antigens, whereas T cells from animals treated with pristane which did not develop arthritis gave much smaller responses. Mice which developed arthritis also had elevated levels of anti‐hsp65 IgG in comparison with non‐arthritic animals. These findings strongly suggest that autoimmune reactions to an antigen which cross‐reacts with hsp65 are generated in pristane‐induced arthritis. It is considered that the autoimmune response is directed to a synovial antigen and that pre‐immunization with hsp65 protects the animals from the development of pristane‐induced arthritis by altering the specificity or quality of the immune response to this antigen.